I hate when people say stuff like that. If it goes to .65, odds are very good it won't come back to this level for some time, why the F! would you want that? Until now, you sounded reasonable, now sound desperate with that idiotic comment. I am admittedly angry, I thought downturn was done 2 days ago. Sensitive diagnostics are the future of healthcare, but they will be cherry picked. I am betting this is one of 'em. But I am not so certain that I enjoy seeing it lose more value, and if you wee honest, neither are you, so just stop.
Just noticed this post. Thanks. I agree completely about the potential for low hanging fruit of CHF management for bringing down the cost of healthcare in the developed world, especially the US. More and more sensitive diagnostics are the killer app in this space, creating an opportunity for very early intervention and avoiding the monstrous costs of an acute or catastrophic episode - that's what's killing the system - the most expensive and least effective therapies are in response to catastrophic events, the damage has been done, prognosis depeleted and the ongoing management and intervention intense.
Question is how many biomarkers will be accommodated? In the case of Galectin-3 and BGMD, Critical Diagnostics (ST2 biomarker) has savaged BGMD and Galectin-3 recently with claims of "clear" superiority. What are your thoughts on that? Is that true in your opinion? Is there room for both tests in the current regimen? Thanks!
mekop, that was yesterday's prediction, he was way off anyway. That said, what a difference a day makes - actually 7 hours or so. Opened this morning with very sizable purchases in the teens, and ends up down 13% from there. I firmly believe diagnostics are a huge part of the future of a sustainable health care system, just got to fine the right one. You'll know it's true when they start an ETF based on small cap medical diagnostics. Galectin-3 may have much broader implications that HF.
Shouldn't mining stocks be getting absolutely hammered today? ABX down 2%, NUGT ETF down 5%. Not sure of it means anything, but last time gold was down here, ABX was in the $13s. Maybe the floor falls out tomorrow. We'll see.
I think you're right. It's red day all around, so people are more likely to take profits if they are there. Too bad, but hopefully it remains above $1
Better diagnostics are the only way to sustain a decent health care system. Acute episodes cost a fortune. Avoiding them saves that fortune. The only way to do that is to detect the problem early, before it becomes catastrophic, and start preventive therapy, including life style changes. Obviously, this will only prevent a % of acute episodes, but the savings will be huge. Hopefully BGMD has just provided an arrow in that quiver.
Thanks, some interesting catalysts also mentioned on CC transcript by CEO. IMO, among the more interesting observations is the fact BGMD traded 43M shares over 2 days at much higher prices. Sure, a lot of churning there, but not all. There is confidence in there somewhere
Great that you guys spend your time taking shots at each other, but considering BGMD is attracting a little attention today, maybe someone should take the time to put some meat on the bones of my question.
Shareholders (SHs), Thanks in Advance (TIA). Not exactly ciphered commie propaganda :-). Even an old timer like me knows 'em. Anyway, original request still stands if anyone interested to have a go. Thank you in advance.
stop with the profanity, who cares. Just be glad he was wrong.
In real news, sort of, Adam Feurstein helped take NWBO close to a 52 week low today with an article predicting failure for its vaccine, just like IMUC. Claims Dendritic based vaccines are useless. Of the 3, that leaves AGEN that just reported impressive P2 and going into a rigorous PIII sponsored and paid for by the NCI.
Nevermind, they reiterated yesterday Dec 16. That's a hell of a call - 550% upside. Analyst will be able to pick his VP chair if he's right.